In partnership with
Protect your identity now with Coveron comprehensive coverage
Identity theft is the fastest-growing crime in America. Criminals don't wait to steal everything, they test stolen identities with small charges before launching major fraud. By the time you notice, they've opened credit cards, taken out loans, or claimed tax refunds in your name.
Coveron watches your credit 24/7, monitors the dark web, and alerts you immediately when suspicious activity is detected. We watch, we warn, we help recover:
Up to $1M to cover identity theft recovery costs.
Up to $10K for losses from online scams.
Up to $50K to cover eligible costs, including payments made in response to the threats.
And with dedicated case managers to handle the legal and financial mess.
One scam can cost you everything - protect yourself now. The first 100 users get 20% off with code beehiivenewsletter.
30-day money-back guarantee. Terms and conditions apply.
LONGEVITY LATEST ISSUE 29 · 23 SEPTEMBER 2026
LONGEVITY LATEST · DEEP DIVE
Strength Before Size
Why strength drifts away from size, what the weight-loss numbers really show, and how to tell whether your own results have changed.
By Christian Thomsen · Companion to Issue 29 · 23 September 2026 · ~7-minute read
You would expect older adults who gain muscle to keep their strength. In the Health ABC study, they did not. Over three years, 1,880 people in their seventies lost leg strength about three times faster than leg lean mass, and those who gained lean mass still, on average, lost strength.
That result is the key to almost every muscle headline, including the ones about weight-loss drugs. Scans measure size; daily life runs on strength and function. Issue 29 set out those three measures. This piece takes the harder questions: why they separate, whether strength buys years, what the weight-loss percentages really mean, and how to read your own retest.
More muscle, less force. Explain that, and most muscle headlines become readable.
Why strength falls faster than size
Four changes can weaken muscle without shrinking it much.
Fat moves in: fat accumulates between and within fibres. The muscle occupies similar space, but less of it contracts.
The wiring is rebuilt: motor neurons are lost with age, and surviving ones adopt the orphaned fibres. Units become fewer and larger, and control becomes coarser.
Activation weakens: the nervous system recruits muscle less completely and less quickly, so the same tissue produces less force.
Force per kilogram falls: together, these lower muscle-specific strength, now one of the three components in the GLIS definition of sarcopenia.
Goodpaster and colleagues read the Health ABC gap the same way: a decline in muscle quality, not only quantity.
The implication cuts both ways. A stable scan can hide a draining reserve, and training can rebuild strength before size catches up. A 12-week pilot trial of 48 adults losing weight showed exactly that: home resistance training improved grip, leg force and chair-stand performance with no measurable change in muscle thickness or lean mass.
Goodpaster et al. Health ABC (2006) · Kirk et al. GLIS (2024) · Binmahfoz et al. home training pilot (2025)
Does strength buy years, or just signal health?
The largest recent test is OPACH: 5,472 women aged 63 to 99, followed for about eight years. After adjusting for health and lifestyle, those in the strongest grip quartile had about a third lower mortality than the weakest (HR 0.67). The association held after accounting for accelerometer-measured activity and sitting time.
A caveat worth noting: strength was measured once, and the study is observational. A published comment on the paper argues that weakness late in life can be a symptom of illness rather than its cause. Both readings can be partly true. Strength is a useful marker either way, and the trial case for building it rests on function, not on mortality.
Reading the weight-loss numbers
Three corrections before any percentage means anything
Headlines about GLP-1 drugs usually quote the share of weight lost as ‘lean mass’. Apply three corrections first.
What was measured: DXA lean mass includes water, organs and connective tissue as well as skeletal muscle; in the mouse studies, liver mass fell faster than muscle mass.
What any weight loss costs: fat tissue itself contains water and protein, so some fat-free mass goes with almost any weight loss. The long-cited rule of thumb is about a quarter, though a 2014 critical review showed how much that varies with starting size, age, activity and measurement method.
What the control arm lost: in an April 2026 Annals of Internal Medicine review of 36 trials, placebo and lifestyle groups also often lost more muscle than expected.
A worked example: a 30% lean share of a 15 kg loss is 4.5 kg of lean tissue. Some of it is not muscle, and some would go with any comparable weight loss. The real questions are how much exceeds that, and whether function follows.
MRI, which images muscle directly, is more reassuring: in SURPASS-3, thigh muscle volume fell roughly as expected for the weight lost. That analysis was post hoc and industry-funded, and it measured tissue, not function.
Langer et al. Cell Reports Medicine (2026) · Heymsfield et al. Obesity Reviews (2014) · Batsis et al. Annals of Internal Medicine (2026) · Sattar et al. SURPASS-3 MRI (2025)
Where the concern is real
The same Annals review still found that muscle-related losses frequently exceeded benchmarks, especially with semaglutide and tirzepatide, and no trial measured objective physical function. The only human strength data in the mouse paper came from a 10-person pilot.
Reassuring MRI, uncomfortable percentages and almost no function data. That is the honest summary.
The people with most at stake are those with least in reserve: older adults, the already frail, and anyone losing weight on top of recent illness or inactivity.
What would upgrade each grade
Issue 29 graded three ways to protect muscle during weight loss. The more useful question is where each grade is weakest, and what evidence would move it.
Resistance training (A): weakest link, almost every trial used dieting rather than GLP-1 drugs. It would be confirmed by trials showing that lifting preserves strength and function during drug-induced weight loss.
Protein (B): weakest link, benefits appear on DXA more reliably than in strength or function. It would move up with trials that hold training constant and improve chair-stand, gait or strength outcomes, not just lean tissue.
Muscle-sparing antibodies (C): weakest link, lean-mass endpoints, short follow-up and an infusion burden. They would move up with larger trials measuring strength, falls or disability objectively, plus longer safety data.
The first of those tests is already running. LEAN-PREP is randomising 232 adults starting semaglutide or tirzepatide to home resistance exercise, protein, both or neither for six months, with MRI thigh muscle as the primary outcome and strength and function measured alongside.
What would change my view: a trial showing that a muscle-sparing strategy reduces falls, disability or loss of independence during drug-induced weight loss, not simply that it preserves more lean tissue.
Five checks on a muscle headline
Measure: was it lean mass, muscle volume, strength or function?
Proportion: is the figure a share of weight lost or an absolute change? A large share of a small loss can be trivial.
Comparator: did a control group losing similar weight lose similar muscle?
Function: was physical performance measured objectively, or only asked about?
Population: were participants older, frail or already weak, or younger adults with reserve to spare?
Run those five before deciding whether a result should change what you do.
Reading your own numbers
Home tests are useful only if you know how much they wobble. Issue 27 made the same point about biological-age clocks: a change smaller than the test’s noise is not a change.
Chair stand: in older women retested under standard conditions, a change had to exceed about 2.5 seconds to count as real. A study of older adults in day care put the figure between roughly 2.3 and 3.1 seconds. Smaller shifts are noise.
Grip: a systematic review suggests changes of about 5 to 6.5 kg are reasonable estimates of a meaningful difference. Keep the device constant: two widely used dynamometers differed by about 3.5 to 4 kg in the same older adults.
Warning thresholds: the European sarcopenia consensus (EWGSOP2) treats grip below 27 kg in men or 16 kg in women, or more than 15 seconds for five chair stands, as low strength in older adults. They are prompts for a clinical conversation, not targets.
Read a single retest cautiously. A drop beyond the noise that repeats on the next test, a result crossing those thresholds, or new difficulty with stairs or rising from the floor deserves a conversation with a clinician, especially during weight loss.
Goldberg et al. (2012) · Yin et al. (2023) · Bohannon (2019) · Benton et al. (2022) · Cruz-Jentoft et al. EWGSOP2 (2019)
If I were designing a protocol from this evidence, it would be boringly simple: two tests, lifting at least twice a week, enough protein, and a retest every two to three months read against the noise. The most expensive item in it is a pair of adjustable dumbbells.
Keep the strength. The scan can follow.
Sources and further reading
Evidence reviewed through 18 September 2026. Strength–mortality associations are observational; bimagrumab and apitegromab are investigational. Detectable-change figures come from specific populations and protocols. Educational content only; do not start, stop or change treatment without a qualified clinician.
© 2026 FrontWave Media Ltd · Longevity Latest
100 Genius Side Hustle Ideas
Don't wait. Sign up for The Hustle to unlock our side hustle database. Unlike generic "start a blog" advice, we've curated 100 actual business ideas with real earning potential, startup costs, and time requirements. Join 1.5M professionals getting smarter about business daily and launch your next money-making venture.